Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | GBA1 | P04062 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12199962 | 1.00 | CA2 (0.31) | CA2GBA1THRBCA1 | |
| SCHEMBL12199997 | 0.98 | GBA1 (0.30) | GBA1 | |
| SCHEMBL12200553 | 0.89 | GBA1 (0.36) | CA2GBA1 | |
| SCHEMBL8729672 | 0.86 | TGFBR1 (0.32) | — | |
| SCHEMBL12200561 | 0.86 | MEN1 (0.37) | CA2GBA1 | |
| SCHEMBL12200560 | 0.83 | CA2 (0.41) | CA2THRB | |
| SCHEMBL1093362 | 0.81 | GBA1 (0.30) | GBA1 | |
| SCHEMBL13146825 | 0.81 | CA2 (0.39) | CA2 | |
| SCHEMBL21504381 | 0.78 | TGFBR1 (0.33) | — | |
| SCHEMBL10339278 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226814-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| US-10087273-B2 | Multifunctional polymers | ISP INVESTMENTS LLC (US) | 2018-10-02 | — | — | US | disclosed |
| US-10010502-B2 | Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation | AMORPHEX THERAPEUTICS LLC (US) | 2018-07-03 | — | — | US | disclosed |
| WO-2016187426-A1 | A DEVICE THAT DELIVERS A SUSTAINED LOW-DOSE OF A MYOPIA-SUPPRESSING DRUG | AMORPHEX THERAPEUTICS LLC (US) | 2016-11-24 | — | — | WO | disclosed |
| US-20160338947-A1 | DEVICE THAT DELIVERS A SUSTAINED LOW-DOSE OF A MYOPIA-SUPPRESSING DRUG, WHILE PRESERVING PUPILLARY FUNCTION AND ACCOMMODATION | AMORPHEX THERAPEUTICS LLC | 2016-11-24 | — | — | US | disclosed |
| US-20150044161-A1 | MULTIFUNCTIONAL POLYMERS | ISP INVESTMENTS INC. (US) | 2015-02-12 | — | — | US | disclosed |
| US-20110242654-A1 | Hardcoat layer-forming composition, optical film, production method of optical film, polarizing plate and image display device | FUJIFILM CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110242191-A1 | INK COMPOSITION, INKJET RECORDING METHOD AND PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20100178315-A1 | POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY | VISTA SCIENTIFIC LLC (US) | 2010-07-15 | — | — | US | disclosed |
| US-20060198892-A1 | Polymeric systems for controlled drug therapy | AMORPHEX THERAPEUTICS LLC | 2006-09-07 | — | — | US | disclosed |
| EP-1656116-A2 | POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY | Vista Scientific LLC (US) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005023181-A2 | POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY | VISTA SCIENTIFIC (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20040247681-A1 | Drug release system for controlled therapy | VISTA SCIENTIFIC LLC | 2004-12-09 | — | — | US | disclosed |
| EP-0425436-B1 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA GEIGY AG (CH) | 1996-12-27 | — | — | EP | disclosed |
| US-5079319-A | Contact Lenses | CIBA-GEIGY CORPORATION (US) | 1992-01-07 | — | — | US | disclosed |
| EP-0425436-A2 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA-GEIGY AG (CH) | 1991-05-02 | — | — | EP | disclosed |
| US-5010141-A | Heat- or UV-curable acrylic resins; coatings; films; biocompatible, water-swelling, oxygen-permeable contact lenses | CIBA-GEIGY CORPORATION (US) | 1991-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160338947-A1 | DEVICE THAT DELIVERS A SUSTAINED LOW-DOSE OF A MYOPIA-SUPPRESSING DRUG, WHILE PRESERVING PUPILLARY FUNCTION AND ACCOMMODATION | MYOC, STRA6, MYOF | CA2 531/4885GBA1 3238/4885THRB 2774/4885 |
| US-10010502-B2 | Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation | MYOC, STRA6, MYOF | CA2 531/4885GBA1 3238/4885THRB 2774/4885 |
| US-20060198892-A1 | Polymeric systems for controlled drug therapy | PAICS, ABCB1, CES2 | CA2 2124/4885GBA1 2007/4885THRB 3542/4885 |
| US-20150044161-A1 | MULTIFUNCTIONAL POLYMERS | PUF60, PARG, PARN | CA2 3586/4885GBA1 2912/4885THRB 4562/4885 |
| US-10087273-B2 | Multifunctional polymers | PUF60, PARG, PARN | CA2 3586/4885GBA1 2912/4885THRB 4562/4885 |
| US-20100178315-A1 | POLYMERIC SYSTEMS FOR CONTROLLED DRUG THERAPY | PAICS, ABCB1, CES2 | CA2 2124/4885GBA1 2007/4885THRB 3542/4885 |
| US-20040247681-A1 | Drug release system for controlled therapy | FKBP2, FKBP3, FKBP1B | CA2 3804/4885GBA1 3597/4885THRB 1871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.